ISRG vs MBOT
ISRG: Intuitive Surgical is the dominant innovator and market leader in robotic-assisted surgical platforms, driving a shift toward minimally invasive clinical outcomes. MBOT: Microbot Medical is an early-stage medical device company developing next-generation robotic endoluminal surgical systems for minimally invasive interventional procedures.
Side-by-side fundamentals
| Metric | ISRG | MBOT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $340.69 | $1.77 | |
| Market cap as of 2026-07-23 | $123.5B | $119M | |
| P/E as of 2026-07-23 | 39.35 | n/a | |
| PEG as of 2026-07-23 | 2.97 | n/a | |
| Net margin as of 2026-07-23 | +28.4% | -3496.2% | ISRG higher |
| Gross margin as of 2026-07-23 | +66.7% | +1.9% | ISRG higher |
| Operating margin as of 2026-07-23 | +31.3% | -4114.3% | ISRG higher |
| ROE as of 2026-07-23 | +17.0% | -21.8% | ISRG higher |
| ROA as of 2026-07-23 | +14.9% | -20.7% | ISRG higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-07-23 | +20.7% | -50.0% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | -56.0% | ISRG higher |
| Beta as of 2026-07-23 | 1.47 | 1.04 | |
| 1-year return as of 2026-07-22 close | -33.3% | -30.0% | MBOT higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.